Emerging Effects of Sevelamer in Chronic Kidney Disease

• Main Authors: Ryota Ikee (Author), Masataka Tsunoda (Author), Naomi Sasaki (Author), Naritsugu Sato (Author), Nobuo Hashimoto (Author)
• Formato: Libro
• Publicado: Karger Publishers, 2013-03-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Sevelamer, a non-absorbable anion exchange resin, is used to control hyperphosphatemia in chronic kidney disease (CKD) by binding to dietary phosphate in the gastrointestinal tract. Lipid-lowering effect is a widely recognized pleiotropic effect of sevelamer. In addition, many studies have reported...